ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Are Natural Products the Solution to Cancer Treatment?

CEDARVILLE, OHIO, June 04, 2024 (GLOBE NEWSWIRE) -- Walking through his village in Nigeria, Dr. Samson Amos, chair and associate professor of pharmaceutical sciences at Cedarville University, heard a woman’s persistent cries.  

Having recently graduated with his Ph.D. in pharmacology from the University of Nigeria, Amos knew he could not ignore his neighbor’s cries. He found her with eyes closed and tears streaming down her face — she had recently been diagnosed with breast cancer.  

Upon hearing Amos’ familiar voice, the woman said, “Samson, please help women like me.” Moved with compassion, Amos knew he was being called to use his gifts to help others through cancer research.  

“I may not have all the answers, but I can depend upon the knowledge that God has given me to find solutions to human disease,” Amos said. “That woman was my first encounter with cancer and since, I’ve seen how cancer affects humanity. I asked God to use me as an instrument to help the world better understand this disease.”  

Amos began working for the National Institute for Pharmaceutical Research in Abuja, Nigeria, as a researcher and professor. There, he studied the effects of natural products — plants, fruits and vegetables — on different disease states, including hypertension, diabetes, malaria and sickle cell disease. Upon moving to the United States in 2000, Amos began training at the University of Virginia so he could better understand the molecular basis of cancer growth, specifically in the brain and prostate. Ten years later, after successfully publishing several research papers on cancer research, Amos joined Cedarville University’s faculty in the school of pharmacy.   

“I was drawn to Cedarville because of its mission and vision,” Amos said. “Most importantly, Cedarville gave me the platform to share my faith and genuinely come alongside students to make a significant kingdom impact.”  

Despite the change of environment, Amos continued studying cancer cells and the molecular basis of cancer growth, while exploring the effects of natural products on various diseases — specifically targeting brain tumors.  

“I wanted to research the use of plant compounds to help in the management of brain tumors and glioblastomas,” Amos said. “When a patient develops a glioblastoma, they are placed on a drug called Temozolomide, which has a minimal clinical outcome. Because of this, I wanted to find out whether there were things in nature that could help us unravel the mystery of this disease and better manage brain tumors.”  

Due to the resistance and low clinical outcomes of Temozolomide on both the tumor and patient, Amos decided to research whether he could use a lower dose of Temozolomide, as well as a small dose of two different natural products found in plants to treat brain tumors as well as other cancers.  

Using an in vitro setting — the use of a bench in the lab as opposed to live animals — Amos and his team of Cedarville Doctor of Pharmacy students studied the effect of both agents to treat brain tumors. The results were overwhelming.  

"Our preliminary data in vitro clearly shows that this combination is synergistic,” Amos said. “When we use a low dose of Temozolomide and our natural product, we have a better biological readout than when we use a higher concentration of Temozolomide.”  

Encouraged by the positive results, Amos plans to continue his research with the help of his students.  

“I have had many Cedarville students from pharmacy, math and science who have expressed interest in our cancer research,” Amos said. “If these students have an interest, it behooves me to train and come alongside them in their passion.”  

Amos’ cancer research is a once-in-a-lifetime opportunity for Cedarville students. Already, their work is being cited in research projects. Other educational institutions are also vying to come alongside Cedarville’s School of Pharmacy in this research.  

But, despite the initial success, Amos sees their research as having a deeper kingdom impact.  

"I want to ensure that when students graduate from Cedarville, they have all that is required for them to be successful clinicians,” Amos said. “But more importantly, I want them to carry Christ into their hospital and allow patients to see the genuine and compassionate care that Christ has for all humanity.”  

Located in southwest Ohio, Cedarville University is a Baptist university with undergraduate programs in arts, sciences, and professional programs, and graduate programs. With an enrollment of 5,456 students in 175 areas of study, Cedarville is one of the largest private universities in Ohio and is recognized nationally for its authentic Christian community, rigorous academic programs, such as the Bachelor of Science in Pharmaceutical Science and Doctor of Pharmacy, and high graduation and retention rates. For more information about the university, visit cedarville.edu.    

Written by Cara Groves, Cedarville Public Relations Student 

Photos by Scott Huck 

Attachments


Mark D. Weinstein
Cedarville University
937-766-8800
mweinstein@cedarville.edu
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.